Sort
46,585 grants matching “heart failure”
Interagency Agreement for Drug Distribution Services for the TOPCAT trial
$897,950National Heart, Lung, And Blood Institute · Y01 · FY2010 · HL
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Julie A Stoner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · HL
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Julie A Stoner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · HL
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Elisa Lee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2013 · HL
Pathophysiology of Myocardial Disease
$897,559Wendy S Post · Johns Hopkins University · T32 · FY2018 · HL
Functional GWAS for LVH using iPS-derived Cardiomyocytes: The HyperGEN ciPS Stud
$897,557Ulrich Broeckel · Medical College Of Wisconsin · U01 · FY2012 · HL
Precision Medicine for Dilated Cardiomyopathy-Cardiac Magnetic Resonance to Identify Early Family Phenotypes
$896,978Ray E Hershberger · Ohio State University · R01 · FY2020 · HL
Melanocortin Ligands in Disease Cachexia
$896,878Kenneth Allen Gruber · Tensive Controls, Inc. · R44 · FY2012 · CA
Impact of Low Flow Nocturnal Oxygen Therapy On Hospital Admissions and Mortality in Patients with Heart Failure and Central Sleep Apnea - DCC
$896,611Susan S Redline · Brigham And Women'S Hospital · U24 · FY2018 · HL
EXTENDED RELEASE TORSEMIDE: PHASE 2
$896,260Peter Uri Feig · Sarfez Pharmaceuticals, Inc. · R44 · FY2015 · DK
Preventing Anthracycline Cardiovascular Toxicity with Statins
$896,071William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2017 · HL
Predictive Modeling for Treatment of Upper Airway Obstruction in Young Children
$896,070Stephanie Duggins Davis · Univ Of North Carolina Chapel Hill · R01 · FY2010 · HL
Hispanic Chronic Renal Insufficiency Cohort(CRIC) Study
$895,708James P Lash · University Of Illinois At Chicago · R01 · FY2011 · DK
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - CORE STUDY OPERATIONS
$895,317Aaron Folsom · University Of Minnesota · N01 · FY2021 · HL
Nest#4-Nerve Excitation Control Through AC Regulation (NECTAR)
$894,784Tina Louise Vrabec · Case Western Reserve University · U41 · FY2023 · NS
Late Effects in Wilms Tumor Survivors and Offspring
$894,610Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Disease-Specific Integrated Microphysiological Human Tissue Models
$893,570Kevin E Healy · University Of California Berkeley · UH2 · FY2012 · TR
Enhancing the Development of New Regenerative Medicine Therapies:Proposal to Build a Robust Clinical Research Development and Data Hub
$893,395Joseph E Finkelstein · Icahn School Of Medicine At Mount Sinai · OT2 · FY2018 · HL
Development and Clinical Testing of CorAide RVAD/BVAD
$893,100Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · HL
Cardiac Toxicity in Perinatally HIV-infected Adolescents and Young Adults, a Longitudinal Study
$893,037Steven Edward Lipshultz · Wayne State University · R01 · FY2017 · HL
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus
$892,710Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2010 · HL
Hypertension Pharmacogenetics
$892,652University Of Florida · R01 · FY2003 · HL
Eicosanoids, Chronic Kidney Disease Progression, and Associated Cardiovascular Risk
$892,433Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2025 · DK
Eicosanoids, Chronic Kidney Disease Progression, and Associated Cardiovascular Risk
$892,433Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2024 · DK
The ISCHEMIA Trial - SDCC
$892,050Robert A Harrington · Duke University · U01 · FY2011 · HL